180 related articles for article (PubMed ID: 19664079)
1. Esophageal manometry in 28 systemic sclerosis Brazilian patients: findings and correlations.
Calderaro DC; de Carvalho MA; Moretzsohn LD
Dis Esophagus; 2009; 22(8):700-4. PubMed ID: 19664079
[TBL] [Abstract][Full Text] [Related]
2. Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients.
Yarze JC; Varga J; Stampfl D; Castell DO; Jimenez SA
Am J Gastroenterol; 1993 Jun; 88(6):870-6. PubMed ID: 8503383
[TBL] [Abstract][Full Text] [Related]
3. Irritable bowel syndrome and organic diseases: a comparative analysis of esophageal motility.
Thomaidis T; Goetz M; Gregor SP; Hoffman A; Kouroumalis E; Moehler M; Galle PR; Schwarting A; Kiesslich R
World J Gastroenterol; 2013 Oct; 19(38):6408-15. PubMed ID: 24151359
[TBL] [Abstract][Full Text] [Related]
4. Esophageal dysmotility associated with systemic sclerosis: a high-resolution manometry study.
Roman S; Hot A; Fabien N; Cordier JF; Miossec P; Ninet J; Mion F;
Dis Esophagus; 2011 Jul; 24(5):299-304. PubMed ID: 21166734
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification.
Aggarwal N; Lopez R; Gabbard S; Wadhwa N; Devaki P; Thota PN
Dis Esophagus; 2017 Dec; 30(12):1-6. PubMed ID: 28881879
[TBL] [Abstract][Full Text] [Related]
6. Frequency of motor alterations detected through manometry in patients with esophageal symptoms and scleroderma.
Pérez Y López N; Lugo-Zamudio G; Barbosa-Cobos RE; Wong-Lam A; Torres-López E
Rev Gastroenterol Mex; 2017; 82(2):193-195. PubMed ID: 28268032
[TBL] [Abstract][Full Text] [Related]
7. The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial.
Karamanolis GP; Panopoulos S; Denaxas K; Karlaftis A; Zorbala A; Kamberoglou D; Ladas SD; Sfikakis PP
Arthritis Res Ther; 2016 Sep; 18(1):195. PubMed ID: 27586891
[TBL] [Abstract][Full Text] [Related]
8. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.
Arif T; Masood Q; Singh J; Hassan I
BMC Gastroenterol; 2015 Feb; 15():24. PubMed ID: 25888470
[TBL] [Abstract][Full Text] [Related]
9. Esophageal dysfunction does not always worsen in systemic sclerosis.
Dantas RO; Meneghelli UG; Oliveira RB; Villanova MG
J Clin Gastroenterol; 1993 Dec; 17(4):281-5. PubMed ID: 8308211
[TBL] [Abstract][Full Text] [Related]
10. [Changes in esophageal peristalsis in diverse clinical forms and antibody specificity in scleroderma: a scintigraphic study in 100 cases].
Cozzi F; Zucchetta P; Durigon N; Marzola MC; Bullo A; Favaro M; Bui F; Todesco S
Reumatismo; 2003; 55(2):86-92. PubMed ID: 12874641
[TBL] [Abstract][Full Text] [Related]
11. Increased inspiratory esophagogastric junction pressure in systemic sclerosis: an add-on to antireflux barrier.
Nobre e Souza MÂ; Bezerra PC; Nobre RA; da Fonseca Holanda ES; dos Santos AA
World J Gastroenterol; 2015 Feb; 21(7):2067-72. PubMed ID: 25717239
[TBL] [Abstract][Full Text] [Related]
12. Esophageal manometry in systemic sclerosis: findings and association with clinical manifestations.
Markus J; Pinto RMC; Matoso AGB; Ranza R
Rev Assoc Med Bras (1992); 2020; 66(1):48-54. PubMed ID: 32130381
[TBL] [Abstract][Full Text] [Related]
13. Assessment of modified Rodnan skin score and esophageal manometry in systemic sclerosis: a study correlating severity of skin and esophageal involvement by objective measures.
Arif T; Adil M; Singh Sodhi J; Hassan I
Acta Dermatovenerol Alp Pannonica Adriat; 2018 Dec; 27(4):169-173. PubMed ID: 30564828
[TBL] [Abstract][Full Text] [Related]
14. Symptoms and esophageal motility based on phenotypic findings of scleroderma.
Tang DM; Pathikonda M; Harrison M; Fisher RS; Friedenberg FK; Parkman HP
Dis Esophagus; 2013; 26(2):197-203. PubMed ID: 22590983
[TBL] [Abstract][Full Text] [Related]
15. Esophageal involvement in mixed connective tissue disease.
Doria A; Bonavina L; Anselmino M; Ruffatti A; Favaretto M; Gambari P; Peracchia A; Todesco S
J Rheumatol; 1991 May; 18(5):685-90. PubMed ID: 1865414
[TBL] [Abstract][Full Text] [Related]
16. Oesophageal manometry in early and definite systemic sclerosis.
Airò P; Della Casa D; Danieli E; Missale G; Cattaneo R; Cestari R
Clin Rheumatol; 2005 Aug; 24(4):370-6. PubMed ID: 15592901
[TBL] [Abstract][Full Text] [Related]
17. The pattern of esophageal manometry in progressive systemic sclerosis.
Al-Amri SM
Saudi Med J; 2003 Jan; 24(1):68-71. PubMed ID: 12590279
[TBL] [Abstract][Full Text] [Related]
18. [Esophageal mucosal lesions and scleroderma: prevalence, symptoms and risk factors].
De Castro Parga ML; Alonso P; García Porrua C; Prada JI
Rev Esp Enferm Dig; 1996 Feb; 88(2):93-8. PubMed ID: 8664079
[TBL] [Abstract][Full Text] [Related]
19. Manometric findings in adult eosinophilic oesophagitis: a study of 12 cases.
Lucendo AJ; Castillo P; Martín-Chávarri S; Carrión G; Pajares R; Pascual JM; Manceñido N; Erdozain JC
Eur J Gastroenterol Hepatol; 2007 May; 19(5):417-24. PubMed ID: 17413294
[TBL] [Abstract][Full Text] [Related]
20. Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study.
Marie I; Levesque H; Ducrotté P; Denis P; Benichou J; Hellot MF; Cailleux N; Le Loët X; Joly P; Lauret P; Courtois H
Arthritis Rheum; 1998 Oct; 41(10):1874-83. PubMed ID: 9778230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
